Pharming which is producing the genetically engineered human lactoferrin has
connections to Numico and others (American Red Cross).  Yes human lactoferrin
is important to them, too.  I read at one site that the reason for adding
genetically engineered human lactoferrin to infant formula is to prevent
hiv/aids.  Very curious....but hiv positive mothers shouldn't breastfeed...oh
yeah I forgot human milk is so infectious...Valerie W. McClain, IBCLC

http://www.bio.org/memberprofile/039939.html


Pharming Group N.V.
P.O. Box 451
Leiden, Netherlands, 2300 AL
Telephone: +31 71 5247 423
Fax: +31 71 5247 456
Website: <A HREF="http://www.bio.org/memberprofile/www.pharming.com">www.pharming.com</A>
Ownership: publicssymbol
Symbol: PHAR
Employees: 200

Contact Person: Prof.Dr. Gerard M.A. van Beynum
Email: <A HREF="mailto:[log in to unmask]">[log in to unmask]</A>

Key Person:
Representative: Gerard M.A. van Beynum
CEO: George J.M. Hersbach
CFO: Ino H.M. Cooijmans
Business Development: Rein Strijker
Marketing/Communications: Gerard M.A. van Beynum
Research: Frank Pieper
Regulatory Affairs: Joost B.M.M. van Bree
HR: Trudy A.A.M. van Twuijver
Company Industry: Biotechnology
Industry Segment: Therapeutics

Company Description:
Pharming focuses on the development, production and commercialization of
human therapeutic proteins to be used in highly innovative therapies. The
company's product portfolio is aimed at treatments for genetic disorders,
surgery and trauma, infectious and inflammatory diseases and tissue damage.
Pharming has developed a proprietary production platform of transgenic
animals, capable of producing human therapeutic proteins at high levels in
their milk.
Pharming has operations in Belgium, Finland, the Netherlands and the USA and
currently employs more than 200 people.

Collaborations:
Genzyme Corp: human alpha-Glucosidase for Pompe's disease
Baxter Healthcare Corp: human C1 Inhibitor for Hereditary Angioedema
American Red Cross: human Fibrinogen for fibrin sealants, human Factor VIII
for Hemophilia A
Infigen, Inc.: nuclear transfer for the generation of transgenic cattle
Royal Numico: human Lactoferrin for nutraceutical applications
Cohesion Technologies/Inamed: human Collagen type I for tissue damage

             ***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html